Alerts
Other content recommended for you
- Intravenous immunoglobulin in neurological disease: a specialist review
- Original research: Second IVIg course in Guillain - Barré syndrome with poor prognosis: the non-randomised ISID study
- Sialylated IgG - Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy
- Small volume plasma exchange for Guillain - Barré syndrome in resource - limited settings: a phase II safety and feasibility study
- What ’s new in Guillain - Barré syndrome
- Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia
- Treatment dilemmas in Guillain - Barré syndrome
- Outcome and its predictors in Guillain – Barré syndrome
- Southern Regional Meeting Abstracts
- Immune responses to myelin proteins in Guillain – Barré syndrome